Jaka jest kapitalizacja rynkowa dla Bloomage BioTechnology Corporation Limited (688363)

Kapitalizacja rynkowa dla Bloomage BioTechnology Corporation Limited (688363) wynosi $2.49B

Bloomage BioTechnology Corporation Limited (688363) Marża Operacyjna

Q: Jaka jest cena za Bloomage BioTechnology Corporation Limited (688363)

Cena za Bloomage BioTechnology Corporation Limited (688363) wynosi $5.21

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.

Rok	Marża operacyjna	Zmień
Za mało danych dla podanych dat.

Rok

Marża operacyjna

Zmień

Za mało danych dla podanych dat.

Firma	Marża operacyjna	Różnica w marży operacyjnej	Kraj
Linde plc LIN.US	28.66%	-	GB
L'Air Liquide S.A. AI.PA	0.00%	-	FR
The Sherwin-Williams Company SHW.US	16.36%	-	US
Ecolab Inc. ECL.US	17.37%	-	US
Air Products and Chemicals, Inc. APD.US	-4.71%	-	US

Firma

Marża operacyjna

Różnica w marży operacyjnej

Kraj